Author:
Johnston Robert L.,Carius Hans-Joachim,Skelly Adrian,Ferreira Alberto,Milnes Fran,Mitchell Paul
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference22 articles.
1. Friedman DS, O’Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol (Chicago, Ill.: 1960) 2004;122:564–572.
2. Mario SP. Global data on visual impairments 2010. http://www.who.int/blindness/GLOBALDATAFINALforweb.pdf . Accessed May 9, 2016.
3. Wong TY, Wong T, Chakravarthy U, et al. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology. 2008;115:116–26.
4. Mitchell P, Bressler N, Doan QV, et al. Estimated cases of blindness and visual impairment from neovascular age-related macular degeneration avoided in australia by ranibizumab treatment. PLoS One. 2014;9:e101072.
5. Johnston RL, Lee AY, Buckle M, et al. UK Age-Related Macular Degeneration Electronic Medical Record System (AMD EMR) Users Group. Report IV: incidence of blindness and sight impairment in ranibizumab-treated patients. Ophthalmology. 2016;123:2386–92.
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献